Clinical Trial Update: Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. [Phase 1]

View source ↗

Summary

Phase I trial update reporting the safety and pharmacokinetics of CRS3123 in participants with Clostridioides difficile infection. The study is reported as comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• CRS3123

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Clostridium Difficile Infection | Phase 1 | Status: COMPLETED